Pharmexa Presents at the 3rd European Breast Cancer Conference in Barcelona
March 20, 2002 11:25 ET
|
Pharmexa A/S
BARCELONA, Spain, March 20, 2002 (PRIMEZONE) -- Dr. Dana Leach, Vice President of Preclinical Development and Immunopharmacology at Pharmexa, today presented the company's HER-2 DNA AutoVac(tm)...